XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Restructuring charges and impairment charges (Tables)
3 Months Ended
Mar. 31, 2019
Restructuring and Related Activities [Abstract]  
Restructuring and Other Impairment Charges
The following tables provide information regarding restructuring and impairment charges recognized by the Company for the three months ended March 31, 2019 and April 1, 2018: 
Three Months Ended March 31, 2019
 
 
 
 
 
 
Termination benefits
 
Other costs (1)
 
Total
 
(Dollars in thousands)
2019 Footprint realignment plan
$
12,975

 
$

 
$
12,975

2018 Footprint realignment plan
$
437

 
$
574

 
$
1,011

Other restructuring programs (2)
126

 
253

 
379

Restructuring charges
$
13,538

 
$
827

 
$
14,365

Asset impairment charges

 
3,030

 
3,030

Restructuring and impairment charges
$
13,538

 
$
3,857

 
$
17,395

Three Months Ended April 1, 2018
 
 
 
 
 
 
Termination benefits
 
Other costs (1)
 
Total
 
(Dollars in thousands)
2016 Footprint realignment plan (3)
1,955

 
194

 
2,149

2014 Footprint realignment plan
116

 
8

 
124

Other restructuring programs (4)
585

 
205

 
790

Restructuring charges
$
2,656

 
$
407

 
$
3,063

(1)
Other costs include facility closure, contract termination and other exit costs.
(2)
Includes the Vascular Solutions integration program (initiated in 2017) as well as the 2016 and 2014 Footprint realignment plans.
(3) The 2016 Footprint realignment plan involved the relocation of certain manufacturing operations, the relocation and outsourcing of certain distribution operations and a related workforce reduction at certain of the Company's facilities. The program is substantially complete and the Company expects future restructuring expenses associated with the program, if any, to be immaterial.
(4) Includes the Vascular Solutions integration program and the EMEA restructuring program (both initiated in 2017).
Summary Of Current Cost Estimates By Major Type Of Cost Table
These actions are expected to be substantially completed during 2022. The following table provides a summary of the Company’s cost estimates by major type of expense associated with the 2019 Footprint realignment plan:
Type of expense
Total estimated amount expected to be incurred
Termination benefits
$19 million to $23 million
Other exit costs (1)
$1 million to $2 million
Restructuring charges
$20 million to $25 million
Restructuring related charges (2)
$36 million to $45 million
Total restructuring and restructuring related charges
$56 million to $70 million
(1)
Includes facility closure, employee relocation, equipment relocation and outplacement costs.
(2)
Restructuring related charges represent costs that are directly related to the 2019 Footprint realignment plan and principally constitute costs to transfer manufacturing operations to existing lower-cost locations, project management costs and accelerated depreciation. Most of these charges are expected to be recognized in cost of goods sold.